Capstone Therapeutics Corp. (CAPS) vs Titan America SA (TTAM)
- Capstone Therapeutics Corp. CAPS 0.09 −10.00%
- Titan America SA TTAM 13.67 −0.07%
Capstone Therapeutics Corp. and Titan America SA are both Building Materials companies. Titan America SA is the larger, with a market value of $2.5B against $2.7M — 947.4× the size. Capstone Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Titan America SA trades at 14.2×. Capstone Therapeutics Corp. grew revenue faster over the last twelve months: 38.9% against 4.07%. Titan America SA has the higher net margin (10.4% vs −36.7%) and the higher return on invested capital (10.2% vs −17.2%). Across the 17 metrics below, Titan America SA leads on 11 and Capstone Therapeutics Corp. on 6.
Valuation
Profitability
| Metric | CAPS | TTAM | Building Materials median |
|---|---|---|---|
| Gross margin | 25.40% | 25.47% | 27.27% |
| Operating margin | (17.20%) | 15.14% | 13.85% |
| Net margin | (36.68%) | 10.35% | 9.59% |
| Free cash flow margin | (6.33%) | 9.10% | 8.06% |
| Return on equity | (114.39%) | 0.00% | 9.62% |
| Return on assets | (41.47%) | 8.96% | 5.86% |
| Return on invested capital | (17.20%) | 10.22% | 6.03% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack